News Feed

December 7, 2023

Vaxess 2023 Year in Review

Vaxess

November 8, 2023

Vaxess Named 2023 Vaccine Innovation of the Year

Vaxess

October 12, 2023

Vaxess Honored in 2023 Bostinno Fire Awards

Vaxess

September 13, 2023

Vaxess Announces $9M in Funding

Vaxess

August 23, 2023

Vaxess to Collaborate with AstraZeneca and Evaluate Novel Patch Delivery Technology for an RNA-based Pandemic Influenza Prototype Vaccine

Vaxess

June 5, 2023

Vaxess Announces Results from Completion of MIMIX-Flu Vaccine Patch Phase 1 Trial

Vaxess

April 25, 2023

Vaxess Announces Messenger Ribonucleic Acid (mRNA) Stability Results from Tests Assessing the Potential for Room-temperature Storage

Vaxess

March 22, 2023

Vaxess Hires Steve Bende, Ph.D., as Chief Strategy Officer

Vaxess

January 10, 2023

Vaxess Announces Additional $10 Million in Funding

Vaxess

December 14, 2022

Vaxess Announces Interim Results from Phase I Clinical Trial of MIMIX-Flu Vaccine Patch

Vaxess

November 29, 2022

Vaxess Adds Fenel Eloi to Board of Directors

Vaxess

November 2, 2022

Vaxess Announces $27M in Series B Funding

The Boston Globe

August 3, 2022

Vaxess Announces Launch of Phase 1Trial for H1 Influenza Vaccine Patch

Vaxess

March 1, 2022

Vaxess Bolsters Commitment To Vaccine Patch Leadership With Purpose-Built Cambridge Lab And Fortified Management Team With The Addition Of A Veteran CFO And Head Of Device Development

BusinessWire

October 26, 2021

Vaxess Technologies Announces Grand Opening of GMP Manufacturing Facility

BusinessWire

April 22, 2021

Vaxess Technologies Awarded NIH Grant of up to $2.85 Million to Drive MIMIX™ Sustained Release Vaccine Patch into a 2022 Phase 1 Human Trial

BusinessWire

January 29, 2021

Ted Hibben joins Vaxess as Chief Business Officer

WFMZ-TV

January 22, 2021

Vaxess Technologies Awarded NSF and DARPA Funding for Development of mRNA-Based Single-Dose, Refrigeration-Free Vaccine Patch

AP News

September 14, 2020

Vaxess Technologies to Develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen

BusinessWire

August 26, 2020

Vaxess Announces Federal Contract for Development of the MIMIX™ Smart Release Patch Platform

BusinessWire

January 10, 2020

Vaxess Technologies to present at Biotech Showcase™ 2020 in San Francisco

Vaxess

October 17, 2019

Vaxess and GC Pharma to Collaborate on Development of of Highly Effective Influenza Vaccine Smart Release Patch

BusinessWire

August 19, 2019

Vaxess Technologies Awarded Grant for Development of the MIMIX-Flu Broadly Protective Influenza Vaccine

Cision PRWeb

June 27, 2019

Vaxess Technologies Closes Final Tranche of $8.2 Million Series A

BusinessWire

October 11, 2018

National Science Foundation Awards

Vaxess

December 1, 2017

National Institutes Of Health Awards

August 15, 2017

Wayne Pisano Joins Vaxess Technologies Advisory Board

March 2, 2017

Vaxess Receives $6 Million from Gates Foundation to Develop Microneedle Patch Vaccines

Yahoo

October 21, 2016

National Science Foundation Awards Follow-on Funding for Development of Heat Stable Vaccines

July 27, 2016

Polio Virologist Mark McKinlay, Ph.D., Joins Vaxess Technologies Advisory Board

May 16, 2016

Vaxess Awarded Two NIH Grants for Stabilization of Biospecimens

April 6, 2015

Vaxess Technologies Awarded NSF and NIH Grants

February 5, 2015

Vaxess Wins $1M Verizon Powerful Answers Award

September 4, 2014

Vaxess Advisors Named Most Influential People in Vaccine

August 28, 2014

PBS NOVA Feature: Stabilizing Vaccines With Silk

PBS NOVA

April 4, 2014

Thomas Monath and Russell Middaugh Join Scientific Advisory Board of Vaxess Technologies

April 1, 2014

Announcing the 2014 ViE Awards Winners

February 4, 2014

Vaxess Adds Vaccine Industry Leader George Siber As Chairman of the Company’s Scientific Advisory Board

September 30, 2013

Vaxess Adds Former Wyeth Executive Jim Connolly to the Company’s Board of Directors

September 16, 2013

Harvard I-Lab Startup Vaxess Using Silk to Preserve Vaccines For Developing Countries

September 12, 2013

Top Individual Awards at 2013 MassTLC Awards Gala Go To…

The Mass Technology Leadership Council

July 19, 2013

MassTLC 2013 Technology Leadership Awards Finalists

May 23, 2013

Aimed at Increasing Vaccine Access, Vaxess Raises the First Part of a $3.75M Series A

The Business Journals

May 23, 2013

Vaxess Announces $3.75M Series A Financing

May 2, 2013

Harvard Business School’s New Venture Competition Announces Winners

VentureFizz

May 1, 2013

Harvard Business School Awards More Than $300k to ‘Entrepreneurship of All Kinds’

January 28, 2013

Harvard I-Lab Sprouts Start-Ups: Nucleik, PollVaultr, Vaxess, & More

Xconomy

August 7, 2012

Vaxess Goes to Harvard

Forbes

July 12, 2012

Along the Silk Road: Improving Vaccine Storage

Harvard Global Health Institute

July 10, 2012

No Sow’s Ear

The Economist

July 9, 2012

Social Entrepreneurship Keeps Life-Saving Vaccines Cool

WGBH

June 19, 2012

How a Diverse Mix of Harvard Students & Tufts’ Technology Can Increase the World’s Vaccine Access

The Business Journals

June 19, 2012

Winning the competition for ideas

Boston Globe

June 19, 2012

i-lab Resident Spotlight: Vaxess

Harvard Innovation Lab

June 19, 2012

4 Harvard Start-ups to Watch

Inc.

June 19, 2012

A Fridge-Free Vaccine Powered By Silk

Fast Company

June 19, 2012

Vaxess wins $70G to develop vaccine strip

Boston Herald

June 18, 2012

Top 20 Schools Handing Out $1.6 Million A Year In Business Plan Contests

June 17, 2012

Harvard Business School Holds 16th Annual Business Plan Contest

June 12, 2012

Harvard entrepreneurs weave silk with science